Evolus Inc (NASDAQ: EOLS) on Tuesday, soared 1.50% from the previous trading day, before settling in for the closing price of $9.98. Within the past 52 weeks, EOLS’s price has moved between $8.67 and $17.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 51.00% over the last five years. The company achieved an average annual earnings per share of 24.40%. With a float of $56.89 million, this company’s outstanding shares have now reached $64.45 million.
The firm has a total of 332 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.73%, operating margin of -14.2%, and the pretax margin is -20.19%.
Evolus Inc (EOLS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Evolus Inc is 11.76%, while institutional ownership is 81.59%. The most recent insider transaction that took place on Mar 27 ’25, was worth 77,512. In this transaction an insider of this company sold 6,251 shares at a rate of $12.40, taking the stock ownership to the 508,619 shares. Before that another transaction happened on Mar 18 ’25, when Company’s insider sold 27,904 for $13.26, making the entire transaction worth $369,868. This insider now owns 362,467 shares in total.
Evolus Inc (EOLS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.40% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Evolus Inc (EOLS) is currently performing well based on its current performance indicators. A quick ratio of 2.16 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach 0.58 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Analysing the last 5-days average volume posted by the [Evolus Inc, EOLS], we can find that recorded value of 1.55 million was better than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 8.86%. Additionally, its Average True Range was 0.74.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 17.28%, which indicates a significant increase from 16.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.92% in the past 14 days, which was lower than the 73.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.74, while its 200-day Moving Average is $13.48. Now, the first resistance to watch is $10.44. This is followed by the second major resistance level at $10.75. The third major resistance level sits at $11.12. If the price goes on to break the first support level at $9.77, it is likely to go to the next support level at $9.40. Now, if the price goes above the second support level, the third support stands at $9.09.
Evolus Inc (NASDAQ: EOLS) Key Stats
Market capitalization of the company is 653.14 million based on 64,476K outstanding shares. Right now, sales total 266,270 K and income totals -50,420 K. The company made 68,520 K in profit during its latest quarter, and -18,890 K in sales during its previous quarter.
